ETFMG Alternative Harvest ETF

Latest ETFMG Alternative Harvest ETF News and Updates

  • uploads///Aphrias Short Interest
    Company & Industry Overviews

    Gauging the Bullish-Bearish Sentiment on Aphria

    The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.

    By Adam Jones
  • uploads///Canopy Growths EPS
    Company & Industry Overviews

    Analysts’ Estimates for Canopy Growth’s Earnings

    Canopy Growth (WEED) (CGC) is expected to report a loss per share of ~0.15 Canadian dollars.

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal

    Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.

    By Adam Jones
  • uploads///Uhhled
    Earnings Report

    Cronos Group Invests in the Future

    Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.

    By Adam Jones
  • uploads///Gross Income and EBITDA Estimates
    Miscellaneous

    Aurora Cannabis: Analysts’ Projections

    Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.

    By Adam Jones
  • uploads///Forward EV to Sales
    Miscellaneous

    Does Cronos Group Look Expensive Compared to Its Peers?

    Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.

    By Adam Jones
  • uploads///marijuana _
    Company & Industry Overviews

    Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’

    Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///can_
    Cannabis

    Cannabis Legalization: Four Governors Met in New York

    The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

    By Rajiv Nanjapla
  • uploads///ebitda
    Real Estate

    Comparing the Valuation Multiples of Cannabis Stocks

    In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.

    By Adam Jones
  • uploads///ITHUF_
    Company & Industry Overviews

    iAnthus to Open Three Dispensaries in Florida by End of 2018

    Today, iAnthus Capital Holdings (ITHUF) announced it will open its first dispensary in Florida on December 19.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Macroeconomic Analysis

    Gundlach Compares Cannabis to Bitcoin

    Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.

    By Anuradha Garg
  • uploads///marijuana hashish leaf flowerpot
    Cannabis

    Big News: Cannabis Edibles in Alberta Stores

    Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

    By Rajiv Nanjapla
  • uploads///Canna
    Company & Industry Overviews

    Kamala Harris: Presidential Candidate for Legalizing Marijuana

    Senator Kamala Harris, who also announced her 2020 presidential bid, supports legalizing marijuana at a federal level.

    By Adam Jones
  • uploads///herb _
    Company & Industry Overviews

    Cannabis Stocks Continue to Struggle on the Last Day of April

    The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.

    By Adam Jones
  • uploads///
    Cannabis

    Cannabis Roundup: HEXO, WEED, ACB, and CTST

    The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.

    By Rajiv Nanjapla
  • uploads///EBITDA Margin FY  Estimates
    Company & Industry Overviews

    What Analysts Estimate for Cannabis Companies’ Earnings Margins

    Let’s now look at how capacity expansion could translate into cannabis companies’ margins.

    By Adam Jones
  • uploads///AdobeStock_
    Cannabis

    Cannabis Sector: A Week in Review for Sept 20

    Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.

    By Adam Jones
  • uploads///canopy growth buy q
    Cannabis

    Why Canopy Growth Is a ‘Buy’ before Its Earnings

    Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?

    By Rajiv Nanjapla
  • uploads///herb _
    Company & Industry Overviews

    Curaleaf Opens Medical Marijuana Dispensary in Tallahassee

    On November 16, Curaleaf Holdings announced that the company opened Tallahassee’s largest medical marijuana dispensary.

    By Mike Benson
  • uploads///
    Cannabis

    Cannabis Stocks Up, Broader Equity Market Falls

    Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

    By Rajiv Nanjapla
  • uploads///part
    Earnings Report

    How Analysts View Cresco Labs before Its Q1 Release

    Cresco Labs (CRLBF) is slated to release its first-quarter earnings on May 29.

    By Mohit Oberoi, CFA
  • uploads///CGC
    Cannabis

    CGC: How the Future Looks Under Its New CEO

    On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.

    By Margaret Patrick
  • uploads///cannabis _
    Company & Industry Overviews

    Cannabis Stocks Had a Mixed Performance Last Week

    Cannabis ETFs traded on a largely negative note last week.

    By Mohit Oberoi, CFA
  • uploads///Part  IIPR
    Company & Industry Overviews

    IIPR Stock Moves Higher after New Debt Is Raised

    Last week, Innovative Industrial Properties (IIPR) offered $125 million in senior notes, giving initial investors the option to exercise $18.75 million in additional principal amount notes.

    By Peter Neil
  • uploads///ACB_
    Cannabis

    Aurora Cannabis Releases Update on Cannabis 2.0

    Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Cannabis Stocks: What Happens in a Recession?

    As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.

    By Margaret Patrick
  • uploads///AdobeStock_
    Cannabis

    What’s the Market Potential for CBD?

    The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

    By Margaret Patrick
  • uploads///Forecast
    Consumer

    Considerations for Investors in Marijuana or Cryptocurrencies

    The forecasting of future cash flows depends on the market potential for legalized medical and recreational marijuana.

    By Adam Jones
  • uploads///mexico
    Cannabis

    Will Mexico Legalize Cannabis by the End of the Month?

    With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.

    By Rajiv Nanjapla
  • uploads///marijuana _
    Company & Industry Overviews

    One Chart That Shows What Makes Cannabis Attractive to Altria

    As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.

    By Adam Jones
  • uploads///can
    Cannabis

    Cannabis Investing in 2019: A Year of Big Reversals

    The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

    By Rajiv Nanjapla
  • uploads///cresco labs
    Cannabis

    Why Origin House’s Acquisition Is Vital for Cresco Labs

    On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.

    By Rajiv Nanjapla
  • uploads///foliage _
    Company & Industry Overviews

    Comparing GW Pharmaceuticals’ Returns to Peers

    GW Pharmaceuticals has received a “strong buy” rating from four analysts, while eight have rated it as a “buy” or some equivalent.

    By Mohit Oberoi, CFA
  • uploads///organigram health canada license
    Cannabis

    OrganiGram Receives Expansion License from Health Canada

    On Monday, OrganiGram Holdings (NASDAQ:OGI) announced that it received a license from Health Canada to expand its Phase 5.

    By Rajiv Nanjapla
  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Comparing Cannabis Stocks’ Valuation Multiples in November

    Aurora Cannabis (ACB) was trading at a multiple of 26.4x, which declined from 34x in October.

    By Adam Jones
  • uploads///
    Cannabis

    Can Canopy Growth’s Q3 Earnings Lift the Cannabis Sector?

    On Friday, Canopy Growth will report its third-quarter earnings before the market opens. Investors will be watching the results closely.

    By Rajiv Nanjapla
  • uploads///organigram analysts revise
    Cannabis

    OrganiGram Stock Falls after Disappointing Q3 Earnings

    Today, OrganiGram Holdings (NASDAQ:OGI) reported its third-quarter earnings. As expected, the results were disappointing.

    By Rajiv Nanjapla
  • uploads///aurora cannabis new cco
    Cannabis

    Aurora Cannabis Appoints New Chief Commercial Officer

    As the demand for Cannabis 2.0 products continues to rise, Aurora Cannabis announced the appointment of Miguel Martin as its new chief commercial officer.

    By Rajiv Nanjapla
  • uploads///curaleaf new jersey
    Cannabis

    Curaleaf Holdings Completes Curaleaf NJ’s Acquisition

    Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

    By Rajiv Nanjapla
  • uploads///hexo israel marijuana
    Cannabis

    HEXO Enters Israel’s Medical Marijuana Market, Stock Surges over 18%

    Today, HEXO announced that it launched its medical marijuana products in Israel. The company signed a two-year agreement with an Israeli cannabis company.

    By Rajiv Nanjapla
  • uploads///aphria and organigram comparing
    Cannabis

    Is Aphria or OrganiGram a Better Buy for Investors?

    Analysts expect Aphria to report revenues of $631.8 million in the next four quarters. Management will focus on the medical and recreational sectors.

    By Rajiv Nanjapla
  • uploads///OGI_
    Cannabis

    What to Expect from OrganiGram’s Q3 Earnings

    OrganiGram will likely report its third-quarter earnings before the market opens on July 21. Overall, there isn’t much hope.

    By Rajiv Nanjapla
  • uploads///curaleaf__
    Cannabis

    Aphria Stock Rose More than 8% after Stifel’s Upgrade

    Aphria (NYSE:APHA) received a bullish call from Stifel. On Monday, Stifel upgraded the stock from a “hold” to a “buy” rating.

    By Rajiv Nanjapla
  • uploads///curaleaf q earnings
    Cannabis

    Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand

    Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.

    By Rajiv Nanjapla
  • uploads///Acb_
    Cannabis

    Why Did Raymond James Downgrade OrganiGram?

    On Monday, Cantech Letter reported that Raymond James downgraded OrganiGram from an “outperform” rating to a “market perform” rating.

    By Rajiv Nanjapla
  • uploads///green thumb store
    Cannabis

    Green Thumb Keeps Expanding Its Operations in Las Vegas

    On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.

    By Rajiv Nanjapla
  • uploads///Canopy_Growth_
    Cannabis

    Canopy Growth Announces Initiatives to Regain Market Share

    In the fourth quarter, Canopy Growth (NYSE:CGC)(TSE:WEED) lost market share due to increased competition in value products.

    By Rajiv Nanjapla
  • uploads///cannabis top  stocks
    Cannabis

    Why Canadian Cannabis Sales Dipped Slightly in April

    In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.

    By Rajiv Nanjapla
  • uploads///medmen relief
    Cannabis

    MedMen’s Medical Marijuana Dispensary License Revoked in Virginia

    The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.

    By Rajiv Nanjapla
  • uploads///Tilray
    Cannabis

    Tilray Rebounded in Q1, Most Analysts Recommend a ‘Hold’

    Tilray hasn’t reported a positive EBITDA yet. Analysts expect the company to become profitable in the first quarter of 2021.

    By Rajiv Nanjapla
  • uploads///us marijuana legal
    Cannabis

    Canopy Growth CEO Expects US to Legalize Cannabis by 2022

    Amid the growing support for cannabis legalization, Canopy Growth (NYSE:CGC) CEO David Klein expects the federal government to legalize marijuana by 2022.

    By Rajiv Nanjapla
  • uploads///cannabis top  stocks
    Cannabis

    Top 2 Cannabis Stocks to Buy, Interest in the Sector Reignites

    After underperforming the broader equity markets in the first quarter, the cannabis sector has been showing a strong recovery in the second quarter.

    By Rajiv Nanjapla
  • uploads///Curaleaf
    Cannabis

    Curaleaf Expands Select Brand Medical Products in Connecticut

    On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.

    By Rajiv Nanjapla
  • uploads///cannabis_
    Cannabis

    Canada’s Cannabis Oil Exports Rose More than 450% in 2019

    Canada, with first-mover advantage, has been exploring new territories to export its cannabis oil. Last year, the company reported to 17 counties.

    By Rajiv Nanjapla
  • uploads///iipr earnings
    Cannabis

    IIPR Acquires Another Property in Pennsylvania

    Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Illinois Reports Record Recreational Cannabis Sales in May

    Illinois sold recreational cannabis worth $44.3 million in May—the highest amount since it legalized recreational sales in January this year.

    By Rajiv Nanjapla
  • uploads///Vireo Health
    Cannabis

    Vireo Health Terminates Bruce Linton as Its Executive Chairman

    On Monday, Vireo Health announced that it terminated Bruce Linton as its executive chairman immediately. He joined the company in November 2019.

    By Rajiv Nanjapla
  • uploads///cannabis stocks broader market
    Cannabis

    Why California’s Legal Cannabis Sales Could Fall This Year

    The budget proposed by Governor Gavin Newsom projected a decline in California’s cannabis sales. COVID-19 induced a recession in the US economy.

    By Rajiv Nanjapla
  • uploads///Tilray
    Cannabis

    Closing Facility Could Cost Tilray $28 Million in Non-Cash Charges

    On May 26, Tilray (NASDAQ:TLRY) announced that it will permanently shut down its High Park Gardens facility located in Leamington, Ontario.

    By Rajiv Nanjapla
  • uploads///Jamaica
    Cannabis

    Why Are Canadian Cannabis Companies Leaving Jamaica?

    Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.

    By Rajiv Nanjapla
  • uploads///Curaleaf
    Cannabis

    Curaleaf: Analysts’ Recommendations after Its Q1 Earnings

    Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.

    By Rajiv Nanjapla
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis to Enter US CBD Market, Stock Rises over 30%

    On Wednesday, Aurora Cannabis (NYSE:ACB) announced that it has signed an agreement to acquire Reliva—a US-based CBD company.

    By Rajiv Nanjapla
  • uploads///curaleaf q earnings
    Cannabis

    Why Did Curaleaf Report a Mixed Q1 Performance?

    On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings

    Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Charlotte’s Web Reports Mixed Q1 Performance

    Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.

    By Rajiv Nanjapla
  • uploads///GW Pharmaceuticals results
    Cannabis

    GW Pharmaceuticals Stock Rises on Higher Epidiolex Sales

    On Monday, GW Pharmaceuticals reported its first-quarter earnings. The company beat analysts’ revenue, EBITDA, and EPS expectations.

    By Rajiv Nanjapla
  • uploads///TLRY
    Cannabis

    Tilray Posts Q1 Results, Stock Falls, and Net Losses Widen

    On Monday, Tilray (NASDAQ:TLRY) reported its first-quarter earnings after the market closed. For the quarter, the company posted revenues of $52.1 million.

    By Rajiv Nanjapla
  • uploads///aphria stock fell
    Cannabis

    Why Did Aphria Stock Fall 7% on May 8?

    On May 8, Aphria’s (NYSE:APHA) management announced that it agreed to repurchase its convertible senior notes from some holders outside of Canada.

    By Rajiv Nanjapla
  • uploads///charlottes web upcoming earnings
    Cannabis

    Why Analysts Are Bullish before Charlotte’s Web’s Q1 Earnings

    Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.

    By Rajiv Nanjapla
  • uploads///tilray_
    Cannabis

    Tilray’s Q1 Earnings Could Boost Its Stock Price

    The meltdown in global financial markets amid COVID-19 dragged Tilray stock down to $2.43 on March 18. Since then, the stock has recovered.

    By Rajiv Nanjapla
  • uploads///iipr earnings
    Cannabis

    IIPR Stock Falls after Reporting Weak Q1 Performance

    On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.

    By Rajiv Nanjapla
  • uploads///APH_
    Cannabis

    Why Has Aphria Risen in Today’s Pre-Trading Hours?

    Today, Aphria (NYSE:APHA) announced that ASG Pharma has received EU GMP certification to produce cannabis for medical and research purposes.

    By Rajiv Nanjapla
  • uploads///aphria attractive
    Cannabis

    Aphria Looks Attractive in the Cannabis Space

    Aphria reported an adjusted EBITDA of $5.7 million in the third quarter. The company has reported a positive EBITDA for four consecutive quarters.

    By Rajiv Nanjapla
  • uploads///CRON_
    Cannabis

    Should You Buy IIPR before Its Q1 Earnings?

    IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?

    By Rajiv Nanjapla
  • uploads///Marijuana
    Cannabis

    Why Is There Optimism before Cresco Labs’ Q4 Earnings?

    Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.

    By Rajiv Nanjapla
  • uploads///Canopy_Growth_
    Cannabis

    Why Did Canopy Growth Stock Rise on Monday?

    Canopy Growth (NYSE:CGC)(TSE:WEED) stock rose to a high of 22.66 Canadian dollars before closing at 21.46 Canadian dollars on Monday.

    By Rajiv Nanjapla
  • uploads///Canopy Growth
    Cannabis

    Canopy Growth to Exit Africa, Close Another Canadian Facility

    Canopy Growth announced another set of global operational changes to optimize its production, improve efficiency, and align its supply with the demand.

    By Rajiv Nanjapla
  • uploads///aphria mixed reactions
    Cannabis

    Why Analysts Had Mixed Reactions to Aphria’s Q3 Earnings

    On April 14, Aphria (NYSE:APHA) reported its third-quarter earnings. For the quarter, the company reported revenues of 144.4 million Canadian dollars.

    By Rajiv Nanjapla
  • uploads///canopy growth aurora cannabis
    Cannabis

    Comparing Canopy Growth and Aurora Cannabis’s Valuation Multiples

    Canopy Growth and Aurora Cannabis are two prominent players in the cannabis sector. So far in 2020, Canopy Growth has outperformed cannabis ETFs.

    By Rajiv Nanjapla
  • uploads///Aphria_
    Cannabis

    Will Aphria’s Q3 Earnings Lift the Cannabis Sector?

    Analysts expect Aphria to report revenue of 130.6 million Canadian dollars in the third quarter—growth of 77.5% YoY and a sequential increase of 8.3%.

    By Rajiv Nanjapla
  • uploads///OrganiGram
    Cannabis

    OrganiGram to Reduce Workforce by 45% Due to COVID-19

    OrganiGram has joined the list of cannabis companies, like Canopy Growth and Aurora Cannabis, that will reduce their workforce.

    By Rajiv Nanjapla
  • uploads///weed cron coronavirus
    Cannabis

    Bruce Linton: WEED and CRON Can Handle COVID-19 Storm

    On April 6, Bruce Linton said that Canopy Growth (TSE:WEED) and Cronos Group (NASDAQ:CRON) are better equipped to withstand the COVID-19 storm.

    By Rajiv Nanjapla
  • uploads///organigram and aphria compare
    Cannabis

    Comparing OrganiGram and Aphria’s Valuation Multiples

    So far this year, OrganiGram Holdings (NASDAQ:OGI) and Aphria (NYSE:APHA) have lost 11.0% and 36.7% of their stock price.

    By Rajiv Nanjapla
  • uploads///cannabis stocks future
    Cannabis

    3 Cannabis Stocks Investors Should Watch as Markets Rebound

    As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.

    By Rajiv Nanjapla
  • uploads///curaleaf earnings results
    Cannabis

    Curaleaf Reports Impressive Q4 Earnings Results

    On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.

    By Rajiv Nanjapla
  • uploads///cannabis stocks broader market
    Cannabis

    Cannabis Stocks Outperformed Broader Equity Markets Last Week

    Last week was the worst week since October 2008. However, the cannabis sector fared better than the broader equity markets.

    By Rajiv Nanjapla
  • uploads///Aphria_OGI
    Cannabis

    Why Did Bank of America Upgrade Aphria and OrganiGram?

    On March 19, Bank of America upgraded Aphria (NYSE:APHA) and OrganiGram Holdings (NASDAQ:OGI) due to the increased demand for cannabis.

    By Rajiv Nanjapla
  • uploads///curaleaf beat expectations
    Cannabis

    Will Curaleaf Beat Analysts’ Expectations in Q4?

    Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.

    By Rajiv Nanjapla
  • uploads///CWEB_
    Cannabis

    What to Expect from Charlotte’s Web’s Q4 Earnings

    Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating

    On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.

    By Rajiv Nanjapla
  • uploads///Marijuana
    Cannabis

    Will the Fed’s Rate Cut Help Marijuana Stocks?

    The marijuana sector saw a sharp decline last week amid the global sell-off. The S&P 500 fell by 8.8% in the week ending on March 13.

    By Rajiv Nanjapla
  • uploads///curaleaf upcoming results
    Cannabis

    Analysts Recommend a ‘Buy’ for Curaleaf before Its Q4 Earnings

    As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”

    By Rajiv Nanjapla
  • uploads///alabama medical marijuana bill
    Cannabis

    Alabama Gets Closer to Legalizing Medical Marijuana

    On Thursday, WBRC reported that the Alabama Senate cleared Senate Bill 165. The bill will create the Compassion Act, which legalizes medical marijuana.

    By Rajiv Nanjapla
  • uploads///IIPR cannabis sector
    Cannabis

    IIPR Looks Promising amid Struggling Cannabis Sector

    As of March 11, Innovative Industrial Properties (NYSE:IIPR) was trading at $76.96—a rise of 1.4% since the beginning of this year.

    By Rajiv Nanjapla
  • uploads///stifel coverage aphria hexo
    Cannabis

    Stifel Initiated Its Coverage on Aphria and HEXO

    On Tuesday, MarketWatch reported that Stifel initiated its coverage on Aphria and HEXO. Stifel gave Aphria a “hold” and HEXO a “sell” rating.

    By Rajiv Nanjapla
  • uploads///canopy growth closes facilities
    Cannabis

    Canopy Growth Will Close Facilities and Cut Jobs

    Yesterday, Canopy Growth (NYSE:CGC)(TSE:WEED) announced that it’s optimizing its operations to align its supply based on demand.

    By Rajiv Nanjapla
  • uploads///Green Growth
    Cannabis

    Charlotte’s Web Reports Improved Yield and CBD Potency

    On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.

    By Rajiv Nanjapla
  • uploads///curaleaf bluekudu
    Cannabis

    How Will Curaleaf Benefit from Acquiring BlueKudu?

    On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.

    By Rajiv Nanjapla
  • uploads///canopy growth why invest
    Cannabis

    Should You Consider Buying Canopy Growth?

    As of February 28, Canopy Growth (NYSE:CGC)(TSE:WEED) was trading at 25.17 Canadian dollars. So far, the company has lost 7.8% of its stock value YTD.

    By Rajiv Nanjapla
  • Market Realist Logo

    © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.